Precision BioSciences (FRA:PBS0) EV-to-Revenue : -0.46 (As of May. 15, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Precision BioSciences's enterprise value is €-24.41 Mil. Precision BioSciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €53.19 Mil. Therefore, Precision BioSciences's EV-to-Revenue for today is -0.46.

The historical rank and industry rank for Precision BioSciences's EV-to-Revenue or its related term are showing as below:

FRA:PBS0' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.49 Med: 3.69 Max: 71.37
Current: -0.54

During the past 7 years, the highest EV-to-Revenue of Precision BioSciences was 71.37. The lowest was -3.49. And the median was 3.69.

FRA:PBS0's EV-to-Revenue is ranked better than
92.87% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs FRA:PBS0: -0.54

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Precision BioSciences's stock price is €11.00. Precision BioSciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €13.50. Therefore, Precision BioSciences's PS Ratio for today is 0.81.

Precision BioSciences EV-to-Revenue Historical Data

The historical data trend for Precision BioSciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences EV-to-Revenue Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

23.82

14.83

2.74

-1.30

-0.82

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-1.53	-1.06	-1.13	-0.82	-

Competitive Comparison of Precision BioSciences's EV-to-Revenue

For the Biotechnology subindustry, Precision BioSciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precision BioSciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's EV-to-Revenue falls into.

Precision BioSciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Precision BioSciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-24.411	/	53.189
	=	-0.46

Precision BioSciences's current Enterprise Value is €-24.41 Mil.
Precision BioSciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €53.19 Mil.

Precision BioSciences (FRA:PBS0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Precision BioSciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	11.00	/	13.499
	=	0.81

Precision BioSciences's share price for today is €11.00.
Precision BioSciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.50.

Precision BioSciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines